德库姆病的全球市场

预计到 2030 年，全球德库姆病市场规模将达到 182 亿美元

2024年，全球德库姆病市场规模估计为129亿美元，预计2030年将达到182亿美元，2024年至2030年的复合年增长率为5.8%。作为报告分析的细分领域之一，外科治疗预计复合年增长率为7.3%，到分析期结束时将达到46亿美元。医疗治疗细分领域在分析期间的复合年增长率估计为4.2%。

美国市场规模估计为 35 亿美元，中国市场预期复合年增长率为 9.4%

美国德库姆病市场规模预计2024年达到35亿美元。作为世界第二大经济体，中国市场规模预计到2030年将达到37亿美元，在2024-2030年的分析期间内，复合年增长率为9.4%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为2.8%和5.8%。在欧洲，预计德国市场的复合年增长率为3.8%。

全球达尔科姆病市场－主要趋势与驱动因素摘要

为什么德库姆病是罕见疾病和疼痛管理研究的热门话题？

德库姆病，又称痛性脂肪组织疾病，是一种罕见的慢性疾病，其特征是身体躯干和四肢出现多发性疼痛性脂肪瘤（脂肪组织增生）。此病主要影响中年女性，但其潜在病理生理机转尚不清楚，导致诊断延迟和治疗方案有限。患者常主诉持续性疼痛、肿胀、疲劳和认知障碍，这些症状严重影响生活品质。儘管德库姆病较为罕见，但由于慢性疼痛症候群、脂质代谢紊乱和罕见疾病的广泛关注，该疾病在医学和製药界正逐渐受到重视。

缺乏明确的诊断标准，以及将症状错误地归类为肥胖相关或心身疾病的倾向，历来导致了漏诊。然而，近年来罕见疾病倡导团体的努力以及影像学和分子诊断技术的进步，正在开始提高疾病的可及性。如今，随着疼痛管理在全球医疗保健中日益重要，Dercum 独特的症状特征正在神经病变和发炎性疼痛的背景下得到更深入的研究。

影响市场需求的治疗挑战和差距是什么？

目前，尚无针对达尔库姆病的核准药物治疗方法。大多数治疗方法针对症状，高度个人化，结合镇痛药、抗发炎药、皮质类固醇和神经病变疼痛药物（例如加巴喷丁类药物和抗忧郁症）。然而，这些治疗方法通常只能提供部分或不持续的缓解，凸显了开发标靶药物和标准化治疗途径的迫切需求。在某些情况下，可以考虑手术切除术脂肪瘤和/或抽脂，但这些方法往往受到復发和术后併发症的限制。

罕见疾病是一种复杂的疾病，涉及代谢、神经和免疫等因素，因此开发治疗方法尤其困难。研究人员正在探索其与自体免疫机制、结缔组织疾病和淋巴功能障碍之间的关联。因此，低剂量纳曲酮、生物製药和淋巴引流疗法等治疗方法正在被探索。然而，由于缺乏大规模临床试验和明确的机制阐明，创新步伐缓慢。这显示罕见疾病治疗市场存在巨大的未满足医疗需求。

研究工作和倡议将如何影响未来的临床策略？

罕见疾病研究界日益增长的兴趣促使人们开展针对德库姆病的流行病学、遗传标记和潜在免疫学基础的新研究。患者登记、数位症状追踪平台和多中心观察性研究为疾病进展、症状丛集和治疗反应提供了宝贵的见解。学术机构、患者权益组织和生物技术公司之间的合作正在推动建立诊断标准、设计临床终点和获得研究资金的势头。

同时，宣传宣传活动和医生教育计画正在帮助提高早期发现和转诊率，尤其是在基层医疗和皮肤科领域。患者报告的结果越来越多地被纳入临床研究，以指导以生活品质为中心的干预措施。这些基层努力正在逐步形成一个更结构化、循证的疾病管理框架，这增加了基于药物和设备的解决方案在未来进入研发阶段的可能性。

支撑达康氏症药物市场发展的关键因素有哪些？

达尔文病市场的成长受到多种因素的推动，包括人们日益认识到慢性疼痛障碍是医疗保健领域的一项重要优先事项，对罕见疾病研究的投资不断增加，以及患者对治疗方法创新的倡导日益高涨。罕见疾病研发激励措施的不断扩大以及监管核准程序的加速，正在鼓励製药公司探索即使是代表性不足的患者群体的治疗潜力。此外，先进影像工具和基于生物标记的研究的发展正在改善疾病识别和患者分层，这对于临床试验设计至关重要。

对个人化医疗和慢性疼痛多学科治疗方案的重视，进一步推动了对整合照护模式的需求。随着公共和私人研究计画对达勒姆病生物学基础的理解不断加深，新的治疗标靶可能会出现，从而刺激对实验性疗法和仿单标示外用药试验的投资。儘管市场仍处于起步阶段，但医学意识、技术创新和监管环境的融合正在为达勒姆病治疗的长期成长奠定基础。

部分

治疗（手术治疗、药物治疗、抽脂治疗、电疗、针灸、其他治疗）、分销管道（医院药房、零售药房、其他分销管道）、最终用户（医院/诊所最终用户、门诊手术中心最终用户、其他最终用户）

受访公司范例（41家值得关注的公司）

• AbbVie Inc.
• Alimed Inc.
• Amgen Inc.
• AstraZeneca plc
• Bausch Health Companies Inc.
• BHR Pharmaceuticals Ltd
• Caliway Biopharmaceuticals
• F. Hoffmann-La Roche Ltd.
• GlaxoSmithKline plc
• Johnson & Johnson Services, Inc.
• Lilly（Eli Lilly and Company）
• Merck & Co., Inc.
• Nivarta, Inc.
• Novartis AG
• Pfizer Inc.
• Raziel Therapeutics Ltd
• Sanofi SA
• Syneron Medical Ltd.
• Takeda Pharmaceutical Company Ltd.
• Teva Pharmaceutical Industries Ltd.

人工智慧集成

我们正在利用可操作的专家内容和人工智慧工具来改变市场和竞争情报。

Global Industry Analysts 并未遵循查询 LLM 或特定产业SLM 的典型规范，而是建立了一个来自全球领域专家的精选内容库，其中包括视讯录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口状况（成品和原始OEM）预测其竞争态势的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括销货成本成本 (COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

• 市场概览
• 主要企业
• 市场趋势和驱动因素
• 全球市场展望

第三章市场分析

• 美国
• 加拿大
• 日本
• 中国
• 欧洲
• 法国
• 德国
• 义大利
• 英国
• 西班牙
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 澳洲
• 印度
• 韩国
• 其他亚太地区
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中东
• 伊朗
• 以色列
• 沙乌地阿拉伯
• 阿拉伯聯合大公国
• 其他中东地区
• 非洲

第四章 竞赛

Global Dercum's Disease Market to Reach US$18.2 Billion by 2030

The global market for Dercum's Disease estimated at US$12.9 Billion in the year 2024, is expected to reach US$18.2 Billion by 2030, growing at a CAGR of 5.8% over the analysis period 2024-2030. Surgery Treatment, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$4.6 Billion by the end of the analysis period. Growth in the Medication Treatment segment is estimated at 4.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.5 Billion While China is Forecast to Grow at 9.4% CAGR

The Dercum's Disease market in the U.S. is estimated at US$3.5 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$3.7 Billion by the year 2030 trailing a CAGR of 9.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.8% and 5.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Global Dercum’s Disease Market - Key Trends & Drivers Summarized

Why Is Dercum’s Disease Gaining Attention in Rare Disease and Pain Management Research?

Dercum’s Disease, also known as Adiposis Dolorosa, is a rare, chronic disorder characterized by the presence of multiple painful lipomas (fatty growths) typically located on the trunk and limbs. Although the condition is predominantly seen in middle-aged women, its underlying pathophysiology remains poorly understood, leading to delayed diagnosis and limited treatment options. Patients frequently report persistent pain, swelling, fatigue, and cognitive disturbances, all of which significantly impair quality of life. Despite its rarity, Dercum’s Disease is gaining increased recognition in the medical and pharmaceutical communities due to the broader focus on chronic pain syndromes, fat metabolism disorders, and orphan diseases.

The lack of definitive diagnostic criteria and the tendency to misclassify symptoms as obesity-related or psychosomatic have historically led to underdiagnosis. However, recent efforts by rare disease advocacy groups and advancements in imaging and molecular diagnostics have started to improve disease visibility. With pain management emerging as a critical component of global healthcare, the unique symptom profile of Dercum’s Disease is now being studied more closely within the context of neuropathic and inflammatory pain disorders.

What Therapeutic Challenges and Treatment Gaps Are Shaping Market Needs?

Currently, there are no approved pharmacological treatments specifically indicated for Dercum’s Disease. Most treatment regimens are symptomatic and highly individualized, involving combinations of analgesics, anti-inflammatory drugs, corticosteroids, and neuropathic pain medications such as gabapentinoids or antidepressants. However, these therapies often yield partial or inconsistent relief, underscoring the urgent need for targeted drug development and standardized care pathways. In some cases, surgical lipoma removal or liposuction is considered, but these approaches are often limited by recurrence and post-operative complications.

The complexity of the disease-intersecting metabolic, neurological, and immunological factors-makes therapeutic development particularly challenging. Researchers are exploring potential links with autoimmune mechanisms, connective tissue disorders, and lymphatic dysfunction. This is leading to exploratory use of treatments such as low-dose naltrexone, biologics, or lymphatic drainage therapies. Nevertheless, the absence of large-scale clinical trials and clear mechanistic understanding has slowed the pace of innovation. This represents a substantial unmet medical need in the rare disease therapeutics market.

How Are Research Efforts and Advocacy Shaping Future Clinical Strategies?

Growing interest from the rare disease research community is prompting new studies into the epidemiology, genetic markers, and potential immunological basis of Dercum’s Disease. Patient registries, digital symptom tracking platforms, and multicenter observational studies are contributing valuable insights into disease progression, symptom clusters, and response to therapy. Collaborations between academic institutions, patient advocacy groups, and biotech startups are creating momentum around establishing diagnostic criteria, designing clinical endpoints, and securing research funding.

In parallel, awareness campaigns and physician education programs are helping improve early detection and referral rates, especially in primary care and dermatology settings. Patient-reported outcomes are increasingly being included in clinical research to guide quality-of-life-focused interventions. These grassroots efforts are gradually shaping a more structured and evidence-based framework for disease management, increasing the likelihood of future pharmaceutical and device-based solutions entering the pipeline.

What Are the Core Drivers Supporting Market Development for Dercum’s Disease Treatments?

The growth in the Dercum’s Disease market is driven by several factors, including increasing recognition of chronic pain disorders as a major healthcare priority, rising investment in rare disease research, and growing patient advocacy pushing for therapeutic innovation. The expansion of orphan drug development incentives and regulatory fast-track programs is encouraging pharmaceutical companies to explore treatment possibilities even in small patient populations. Additionally, the development of advanced diagnostic imaging tools and biomarker-based research is improving disease identification and patient stratification, which are essential for clinical trial design.

The emphasis on personalized medicine and multidisciplinary approaches to chronic pain is further supporting demand for integrated care models. As public and private research initiatives continue to map the biological underpinnings of Dercum’s Disease, new therapeutic targets may emerge, driving investment in experimental treatments and off-label drug trials. While the market remains nascent, the convergence of medical awareness, technological innovation, and regulatory support is laying the groundwork for long-term growth in the Dercum’s Disease therapeutic landscape.

SCOPE OF STUDY:

The report analyzes the Dercum's Disease market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Treatment (Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment, Other Treatments); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels); End-Use (Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

• AbbVie Inc.
• Alimed Inc.
• Amgen Inc.
• AstraZeneca plc
• Bausch Health Companies Inc.
• BHR Pharmaceuticals Ltd
• Caliway Biopharmaceuticals
• F. Hoffmann-La Roche Ltd.
• GlaxoSmithKline plc
• Johnson & Johnson Services, Inc.
• Lilly (Eli Lilly and Company)
• Merck & Co., Inc.
• Nivarta, Inc.
• Novartis AG
• Pfizer Inc.
• Raziel Therapeutics Ltd
• Sanofi S.A.
• Syneron Medical Ltd.
• Takeda Pharmaceutical Company Ltd.
• Teva Pharmaceutical Industries Ltd.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Dercum's Disease - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Increased Awareness of Rare Adipose Tissue Disorders Propels Research Interest in Dercums Disease
  • Rising Focus on Pain Management and Quality of Life in Rare Disease Populations Strengthens Need for Targeted Therapies
  • Expansion of Diagnostic Imaging and Genetic Screening Tools Throws the Spotlight on Underdiagnosed Lipomatosis Disorders
  • Absence of Approved Treatments Promotes Off-Label Use of Analgesics, Steroids, and Hormonal Agents
  • Growth in Patient Advocacy and Online Health Forums Raises Visibility and Clinical Recognition
  • Use of Compression Therapy, Lidocaine Infusion, and Surgical Debulking Fuels Interest in Interventional Approaches
  • Integration of Multidisciplinary Care Models Encourages Pain Clinics to Explore Dercums Management
  • Limited Clinical Trial Participation Challenges Therapeutic Validation and Commercial Development
  • Expansion of Rare Disease Funding Mechanisms Supports Early-Stage Research and Biomarker Discovery
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Dercum's Disease Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Dercum's Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Dercum's Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Dercum's Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Surgery Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Surgery Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Surgery Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Medication Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Medication Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Medication Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Liposuction Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Liposuction Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Liposuction Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Electrotherapy Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Electrotherapy Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Electrotherapy Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Acupuncture Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Acupuncture Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Acupuncture Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Other Treatments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Other Treatments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Other Treatments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Hospital & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Hospital & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Hospital & Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 31: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 34: World 16-Year Perspective for Hospital Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 37: World 16-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 40: World 16-Year Perspective for Other Distribution Channels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Dercum's Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 41: USA Recent Past, Current & Future Analysis for Dercum's Disease by Treatment - Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Dercum's Disease by Treatment - Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 43: USA 16-Year Perspective for Dercum's Disease by Treatment - Percentage Breakdown of Value Sales for Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments for the Years 2014, 2025 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for Dercum's Disease by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Dercum's Disease by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 46: USA 16-Year Perspective for Dercum's Disease by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for Dercum's Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Dercum's Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 49: USA 16-Year Perspective for Dercum's Disease by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Dercum's Disease by Treatment - Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Dercum's Disease by Treatment - Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 52: Canada 16-Year Perspective for Dercum's Disease by Treatment - Percentage Breakdown of Value Sales for Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments for the Years 2014, 2025 & 2030
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Dercum's Disease by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Dercum's Disease by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 55: Canada 16-Year Perspective for Dercum's Disease by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Dercum's Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Dercum's Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 58: Canada 16-Year Perspective for Dercum's Disease by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2014, 2025 & 2030
• JAPAN
  • Dercum's Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Dercum's Disease by Treatment - Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Dercum's Disease by Treatment - Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 61: Japan 16-Year Perspective for Dercum's Disease by Treatment - Percentage Breakdown of Value Sales for Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments for the Years 2014, 2025 & 2030
  • TABLE 62: Japan Recent Past, Current & Future Analysis for Dercum's Disease by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for Dercum's Disease by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 64: Japan 16-Year Perspective for Dercum's Disease by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Dercum's Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Dercum's Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 67: Japan 16-Year Perspective for Dercum's Disease by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2014, 2025 & 2030
• CHINA
  • Dercum's Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 68: China Recent Past, Current & Future Analysis for Dercum's Disease by Treatment - Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: China Historic Review for Dercum's Disease by Treatment - Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 70: China 16-Year Perspective for Dercum's Disease by Treatment - Percentage Breakdown of Value Sales for Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments for the Years 2014, 2025 & 2030
  • TABLE 71: China Recent Past, Current & Future Analysis for Dercum's Disease by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: China Historic Review for Dercum's Disease by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 73: China 16-Year Perspective for Dercum's Disease by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 74: China Recent Past, Current & Future Analysis for Dercum's Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for Dercum's Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 76: China 16-Year Perspective for Dercum's Disease by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2014, 2025 & 2030
• EUROPE
  • Dercum's Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Dercum's Disease by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Dercum's Disease by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 79: Europe 16-Year Perspective for Dercum's Disease by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Dercum's Disease by Treatment - Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Dercum's Disease by Treatment - Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 82: Europe 16-Year Perspective for Dercum's Disease by Treatment - Percentage Breakdown of Value Sales for Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments for the Years 2014, 2025 & 2030
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Dercum's Disease by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Dercum's Disease by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 85: Europe 16-Year Perspective for Dercum's Disease by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Dercum's Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Dercum's Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 88: Europe 16-Year Perspective for Dercum's Disease by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2014, 2025 & 2030
• FRANCE
  • Dercum's Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 89: France Recent Past, Current & Future Analysis for Dercum's Disease by Treatment - Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: France Historic Review for Dercum's Disease by Treatment - Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 91: France 16-Year Perspective for Dercum's Disease by Treatment - Percentage Breakdown of Value Sales for Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments for the Years 2014, 2025 & 2030
  • TABLE 92: France Recent Past, Current & Future Analysis for Dercum's Disease by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: France Historic Review for Dercum's Disease by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 94: France 16-Year Perspective for Dercum's Disease by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 95: France Recent Past, Current & Future Analysis for Dercum's Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: France Historic Review for Dercum's Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 97: France 16-Year Perspective for Dercum's Disease by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2014, 2025 & 2030
• GERMANY
  • Dercum's Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 98: Germany Recent Past, Current & Future Analysis for Dercum's Disease by Treatment - Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Germany Historic Review for Dercum's Disease by Treatment - Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 100: Germany 16-Year Perspective for Dercum's Disease by Treatment - Percentage Breakdown of Value Sales for Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments for the Years 2014, 2025 & 2030
  • TABLE 101: Germany Recent Past, Current & Future Analysis for Dercum's Disease by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Germany Historic Review for Dercum's Disease by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 103: Germany 16-Year Perspective for Dercum's Disease by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 104: Germany Recent Past, Current & Future Analysis for Dercum's Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Germany Historic Review for Dercum's Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 106: Germany 16-Year Perspective for Dercum's Disease by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 107: Italy Recent Past, Current & Future Analysis for Dercum's Disease by Treatment - Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Italy Historic Review for Dercum's Disease by Treatment - Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 109: Italy 16-Year Perspective for Dercum's Disease by Treatment - Percentage Breakdown of Value Sales for Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments for the Years 2014, 2025 & 2030
  • TABLE 110: Italy Recent Past, Current & Future Analysis for Dercum's Disease by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Italy Historic Review for Dercum's Disease by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 112: Italy 16-Year Perspective for Dercum's Disease by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 113: Italy Recent Past, Current & Future Analysis for Dercum's Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Italy Historic Review for Dercum's Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 115: Italy 16-Year Perspective for Dercum's Disease by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Dercum's Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 116: UK Recent Past, Current & Future Analysis for Dercum's Disease by Treatment - Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: UK Historic Review for Dercum's Disease by Treatment - Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 118: UK 16-Year Perspective for Dercum's Disease by Treatment - Percentage Breakdown of Value Sales for Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments for the Years 2014, 2025 & 2030
  • TABLE 119: UK Recent Past, Current & Future Analysis for Dercum's Disease by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: UK Historic Review for Dercum's Disease by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 121: UK 16-Year Perspective for Dercum's Disease by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 122: UK Recent Past, Current & Future Analysis for Dercum's Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: UK Historic Review for Dercum's Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 124: UK 16-Year Perspective for Dercum's Disease by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 125: Spain Recent Past, Current & Future Analysis for Dercum's Disease by Treatment - Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Spain Historic Review for Dercum's Disease by Treatment - Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 127: Spain 16-Year Perspective for Dercum's Disease by Treatment - Percentage Breakdown of Value Sales for Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments for the Years 2014, 2025 & 2030
  • TABLE 128: Spain Recent Past, Current & Future Analysis for Dercum's Disease by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Spain Historic Review for Dercum's Disease by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 130: Spain 16-Year Perspective for Dercum's Disease by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 131: Spain Recent Past, Current & Future Analysis for Dercum's Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Spain Historic Review for Dercum's Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 133: Spain 16-Year Perspective for Dercum's Disease by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 134: Russia Recent Past, Current & Future Analysis for Dercum's Disease by Treatment - Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Russia Historic Review for Dercum's Disease by Treatment - Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 136: Russia 16-Year Perspective for Dercum's Disease by Treatment - Percentage Breakdown of Value Sales for Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments for the Years 2014, 2025 & 2030
  • TABLE 137: Russia Recent Past, Current & Future Analysis for Dercum's Disease by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Russia Historic Review for Dercum's Disease by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 139: Russia 16-Year Perspective for Dercum's Disease by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 140: Russia Recent Past, Current & Future Analysis for Dercum's Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Russia Historic Review for Dercum's Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 142: Russia 16-Year Perspective for Dercum's Disease by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Dercum's Disease by Treatment - Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Rest of Europe Historic Review for Dercum's Disease by Treatment - Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 145: Rest of Europe 16-Year Perspective for Dercum's Disease by Treatment - Percentage Breakdown of Value Sales for Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments for the Years 2014, 2025 & 2030
  • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Dercum's Disease by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Rest of Europe Historic Review for Dercum's Disease by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 148: Rest of Europe 16-Year Perspective for Dercum's Disease by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Dercum's Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Rest of Europe Historic Review for Dercum's Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 151: Rest of Europe 16-Year Perspective for Dercum's Disease by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Dercum's Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Dercum's Disease by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Dercum's Disease by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 16-Year Perspective for Dercum's Disease by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Dercum's Disease by Treatment - Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Dercum's Disease by Treatment - Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 16-Year Perspective for Dercum's Disease by Treatment - Percentage Breakdown of Value Sales for Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments for the Years 2014, 2025 & 2030
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Dercum's Disease by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for Dercum's Disease by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 16-Year Perspective for Dercum's Disease by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Dercum's Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Asia-Pacific Historic Review for Dercum's Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 163: Asia-Pacific 16-Year Perspective for Dercum's Disease by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Dercum's Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 164: Australia Recent Past, Current & Future Analysis for Dercum's Disease by Treatment - Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Australia Historic Review for Dercum's Disease by Treatment - Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 166: Australia 16-Year Perspective for Dercum's Disease by Treatment - Percentage Breakdown of Value Sales for Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments for the Years 2014, 2025 & 2030
  • TABLE 167: Australia Recent Past, Current & Future Analysis for Dercum's Disease by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Australia Historic Review for Dercum's Disease by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 169: Australia 16-Year Perspective for Dercum's Disease by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 170: Australia Recent Past, Current & Future Analysis for Dercum's Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Australia Historic Review for Dercum's Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 172: Australia 16-Year Perspective for Dercum's Disease by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2014, 2025 & 2030
• INDIA
  • Dercum's Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 173: India Recent Past, Current & Future Analysis for Dercum's Disease by Treatment - Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: India Historic Review for Dercum's Disease by Treatment - Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 175: India 16-Year Perspective for Dercum's Disease by Treatment - Percentage Breakdown of Value Sales for Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments for the Years 2014, 2025 & 2030
  • TABLE 176: India Recent Past, Current & Future Analysis for Dercum's Disease by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: India Historic Review for Dercum's Disease by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 178: India 16-Year Perspective for Dercum's Disease by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 179: India Recent Past, Current & Future Analysis for Dercum's Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: India Historic Review for Dercum's Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 181: India 16-Year Perspective for Dercum's Disease by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 182: South Korea Recent Past, Current & Future Analysis for Dercum's Disease by Treatment - Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: South Korea Historic Review for Dercum's Disease by Treatment - Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 184: South Korea 16-Year Perspective for Dercum's Disease by Treatment - Percentage Breakdown of Value Sales for Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments for the Years 2014, 2025 & 2030
  • TABLE 185: South Korea Recent Past, Current & Future Analysis for Dercum's Disease by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: South Korea Historic Review for Dercum's Disease by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 187: South Korea 16-Year Perspective for Dercum's Disease by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 188: South Korea Recent Past, Current & Future Analysis for Dercum's Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: South Korea Historic Review for Dercum's Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 190: South Korea 16-Year Perspective for Dercum's Disease by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Dercum's Disease by Treatment - Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Asia-Pacific Historic Review for Dercum's Disease by Treatment - Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 193: Rest of Asia-Pacific 16-Year Perspective for Dercum's Disease by Treatment - Percentage Breakdown of Value Sales for Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments for the Years 2014, 2025 & 2030
  • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Dercum's Disease by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Asia-Pacific Historic Review for Dercum's Disease by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 196: Rest of Asia-Pacific 16-Year Perspective for Dercum's Disease by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Dercum's Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Asia-Pacific Historic Review for Dercum's Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 199: Rest of Asia-Pacific 16-Year Perspective for Dercum's Disease by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Dercum's Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Dercum's Disease by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Dercum's Disease by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 202: Latin America 16-Year Perspective for Dercum's Disease by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Dercum's Disease by Treatment - Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Dercum's Disease by Treatment - Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 205: Latin America 16-Year Perspective for Dercum's Disease by Treatment - Percentage Breakdown of Value Sales for Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments for the Years 2014, 2025 & 2030
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for Dercum's Disease by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for Dercum's Disease by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 208: Latin America 16-Year Perspective for Dercum's Disease by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 209: Latin America Recent Past, Current & Future Analysis for Dercum's Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Latin America Historic Review for Dercum's Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 211: Latin America 16-Year Perspective for Dercum's Disease by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 212: Argentina Recent Past, Current & Future Analysis for Dercum's Disease by Treatment - Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Argentina Historic Review for Dercum's Disease by Treatment - Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 214: Argentina 16-Year Perspective for Dercum's Disease by Treatment - Percentage Breakdown of Value Sales for Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments for the Years 2014, 2025 & 2030
  • TABLE 215: Argentina Recent Past, Current & Future Analysis for Dercum's Disease by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Argentina Historic Review for Dercum's Disease by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 217: Argentina 16-Year Perspective for Dercum's Disease by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 218: Argentina Recent Past, Current & Future Analysis for Dercum's Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Argentina Historic Review for Dercum's Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 220: Argentina 16-Year Perspective for Dercum's Disease by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 221: Brazil Recent Past, Current & Future Analysis for Dercum's Disease by Treatment - Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Brazil Historic Review for Dercum's Disease by Treatment - Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 223: Brazil 16-Year Perspective for Dercum's Disease by Treatment - Percentage Breakdown of Value Sales for Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments for the Years 2014, 2025 & 2030
  • TABLE 224: Brazil Recent Past, Current & Future Analysis for Dercum's Disease by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Brazil Historic Review for Dercum's Disease by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 226: Brazil 16-Year Perspective for Dercum's Disease by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 227: Brazil Recent Past, Current & Future Analysis for Dercum's Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Brazil Historic Review for Dercum's Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 229: Brazil 16-Year Perspective for Dercum's Disease by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 230: Mexico Recent Past, Current & Future Analysis for Dercum's Disease by Treatment - Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Mexico Historic Review for Dercum's Disease by Treatment - Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 232: Mexico 16-Year Perspective for Dercum's Disease by Treatment - Percentage Breakdown of Value Sales for Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments for the Years 2014, 2025 & 2030
  • TABLE 233: Mexico Recent Past, Current & Future Analysis for Dercum's Disease by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Mexico Historic Review for Dercum's Disease by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 235: Mexico 16-Year Perspective for Dercum's Disease by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 236: Mexico Recent Past, Current & Future Analysis for Dercum's Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Mexico Historic Review for Dercum's Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 238: Mexico 16-Year Perspective for Dercum's Disease by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Dercum's Disease by Treatment - Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Latin America Historic Review for Dercum's Disease by Treatment - Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 241: Rest of Latin America 16-Year Perspective for Dercum's Disease by Treatment - Percentage Breakdown of Value Sales for Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments for the Years 2014, 2025 & 2030
  • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Dercum's Disease by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Latin America Historic Review for Dercum's Disease by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 244: Rest of Latin America 16-Year Perspective for Dercum's Disease by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Dercum's Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Latin America Historic Review for Dercum's Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 247: Rest of Latin America 16-Year Perspective for Dercum's Disease by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Dercum's Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Dercum's Disease by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Dercum's Disease by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 250: Middle East 16-Year Perspective for Dercum's Disease by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Dercum's Disease by Treatment - Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Dercum's Disease by Treatment - Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 253: Middle East 16-Year Perspective for Dercum's Disease by Treatment - Percentage Breakdown of Value Sales for Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments for the Years 2014, 2025 & 2030
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for Dercum's Disease by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for Dercum's Disease by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 256: Middle East 16-Year Perspective for Dercum's Disease by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 257: Middle East Recent Past, Current & Future Analysis for Dercum's Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Middle East Historic Review for Dercum's Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 259: Middle East 16-Year Perspective for Dercum's Disease by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 260: Iran Recent Past, Current & Future Analysis for Dercum's Disease by Treatment - Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Iran Historic Review for Dercum's Disease by Treatment - Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 262: Iran 16-Year Perspective for Dercum's Disease by Treatment - Percentage Breakdown of Value Sales for Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments for the Years 2014, 2025 & 2030
  • TABLE 263: Iran Recent Past, Current & Future Analysis for Dercum's Disease by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Iran Historic Review for Dercum's Disease by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 265: Iran 16-Year Perspective for Dercum's Disease by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 266: Iran Recent Past, Current & Future Analysis for Dercum's Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Iran Historic Review for Dercum's Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 268: Iran 16-Year Perspective for Dercum's Disease by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 269: Israel Recent Past, Current & Future Analysis for Dercum's Disease by Treatment - Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Israel Historic Review for Dercum's Disease by Treatment - Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 271: Israel 16-Year Perspective for Dercum's Disease by Treatment - Percentage Breakdown of Value Sales for Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments for the Years 2014, 2025 & 2030
  • TABLE 272: Israel Recent Past, Current & Future Analysis for Dercum's Disease by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Israel Historic Review for Dercum's Disease by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 274: Israel 16-Year Perspective for Dercum's Disease by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 275: Israel Recent Past, Current & Future Analysis for Dercum's Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Israel Historic Review for Dercum's Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 277: Israel 16-Year Perspective for Dercum's Disease by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Dercum's Disease by Treatment - Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Saudi Arabia Historic Review for Dercum's Disease by Treatment - Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 280: Saudi Arabia 16-Year Perspective for Dercum's Disease by Treatment - Percentage Breakdown of Value Sales for Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments for the Years 2014, 2025 & 2030
  • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Dercum's Disease by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Saudi Arabia Historic Review for Dercum's Disease by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 283: Saudi Arabia 16-Year Perspective for Dercum's Disease by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Dercum's Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Saudi Arabia Historic Review for Dercum's Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 286: Saudi Arabia 16-Year Perspective for Dercum's Disease by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 287: UAE Recent Past, Current & Future Analysis for Dercum's Disease by Treatment - Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: UAE Historic Review for Dercum's Disease by Treatment - Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 289: UAE 16-Year Perspective for Dercum's Disease by Treatment - Percentage Breakdown of Value Sales for Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments for the Years 2014, 2025 & 2030
  • TABLE 290: UAE Recent Past, Current & Future Analysis for Dercum's Disease by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: UAE Historic Review for Dercum's Disease by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 292: UAE 16-Year Perspective for Dercum's Disease by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 293: UAE Recent Past, Current & Future Analysis for Dercum's Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: UAE Historic Review for Dercum's Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 295: UAE 16-Year Perspective for Dercum's Disease by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Dercum's Disease by Treatment - Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Middle East Historic Review for Dercum's Disease by Treatment - Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 298: Rest of Middle East 16-Year Perspective for Dercum's Disease by Treatment - Percentage Breakdown of Value Sales for Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments for the Years 2014, 2025 & 2030
  • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Dercum's Disease by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Middle East Historic Review for Dercum's Disease by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 301: Rest of Middle East 16-Year Perspective for Dercum's Disease by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Dercum's Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Middle East Historic Review for Dercum's Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 304: Rest of Middle East 16-Year Perspective for Dercum's Disease by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2014, 2025 & 2030
• AFRICA
  • Dercum's Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 305: Africa Recent Past, Current & Future Analysis for Dercum's Disease by Treatment - Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Africa Historic Review for Dercum's Disease by Treatment - Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 307: Africa 16-Year Perspective for Dercum's Disease by Treatment - Percentage Breakdown of Value Sales for Surgery Treatment, Medication Treatment, Liposuction Treatment, Electrotherapy Treatment, Acupuncture Treatment and Other Treatments for the Years 2014, 2025 & 2030
  • TABLE 308: Africa Recent Past, Current & Future Analysis for Dercum's Disease by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Africa Historic Review for Dercum's Disease by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 310: Africa 16-Year Perspective for Dercum's Disease by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 311: Africa Recent Past, Current & Future Analysis for Dercum's Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Africa Historic Review for Dercum's Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 313: Africa 16-Year Perspective for Dercum's Disease by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2014, 2025 & 2030

IV. COMPETITION